Danaher Corporation (DHR) Revenue by Segment
Danaher revenue by segment at a glance
In Q2 fiscal 2026 (the quarter ended June 26, 2026), Danaher's largest business segment was Diagnostics, with $2.47 billion or 39% of revenue, up 6.8% from a year earlier. Next: Biotechnology (31%) and Life Sciences (30%).
By product or service, Revenue from Contract with Customer, Measurement, Recurring brought in 83% and Revenue from Contract with Customer, Measurement, Nonrecurring brought in 17% of revenue in Q2 fiscal 2026.
By region, North America brought in 39%, High-Growth Markets brought in 31% and Western Europe brought in 25% of revenue in Q2 fiscal 2026.
The fastest-growing business segment from a year earlier was Diagnostics (+6.8%).
From company filings, in USD; latest quarter ended June 26, 2026; quarterly data from Q3 fiscal 2017.
Danaher Corporation
Revenue breakdown
Fiscal quarters, from company filings
Danaher revenue by business segment, last 4 quarters
| Business segment | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Diagnostics | $2.5B | $2.4B | $2.5B | $2.3B | 39% |
| Biotechnology | $1.9B | $1.8B | $1.8B | $1.9B | 31% |
| Life Sciences | $1.9B | $1.7B | $1.8B | $1.8B | 30% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Danaher revenue by product or service, last 4 quarters
| Product or service | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| Revenue from Contract with Customer, Measurement, Recurring | $5.2B | $5.0B | $5.0B | $5.0B | 83% |
| Revenue from Contract with Customer, Measurement, Nonrecurring | $1.1B | $920.0M | $1.0B | $966.0M | 17% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Danaher revenue by region, last 4 quarters
| Region | Q2 FY26 | Q1 FY26 | Q3 FY25 | Q2 FY25 | Share |
|---|---|---|---|---|---|
| North America | $2.5B | $2.5B | $2.6B | $2.4B | 39% |
| High-Growth Markets | $2.0B | $1.6B | $1.8B | $1.7B | 31% |
| Western Europe | $1.5B | $1.6B | $1.4B | $1.5B | 25% |
| Other Developed Markets | $293.0M | $284.0M | $316.0M | $294.0M | 5% |
In USD, fiscal quarters as reported; share = part of Q2 FY26 revenue.
Questions and answers
What are Danaher's business segments?
Diagnostics, Biotechnology and Life Sciences (as reported for Q2 fiscal 2026).
Which business segment makes the most money for Danaher?
Diagnostics: $2.47 billion, or 39% of revenue, in Q2 fiscal 2026.
What are Danaher's main products and services?
By revenue in Q2 fiscal 2026: Revenue from Contract with Customer, Measurement, Recurring (83%) and Revenue from Contract with Customer, Measurement, Nonrecurring (17%).
Where does Danaher make its money?
By region in Q2 fiscal 2026: North America (39%), High-Growth Markets (31%), Western Europe (25%) and Other Developed Markets (5%).
